Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Ann Surg Oncol. 2022 Apr;29(4):2176-2180. doi: 10.1245/s10434-021-10217-5. Epub 2021 Jun 7.
The Society of Surgical Oncology is committed to reducing health disparities adversely affecting sexual and gender minorities. Transgender persons represent a socially disadvantaged group who frequently experience discrimination and receive disparate care, resulting in suboptimal cancer outcomes. The rate of breast cancer development in transgender individuals differs from rates observed in their cisgender counterparts, however there is little evidence to quantify these differences and guide evidence-based screening and prevention. There is no consensus for breast cancer screening guidelines in transgender patients. In this review, we discuss barriers to equitable breast cancer care, risk factors for breast cancer development, and existing data to support breast cancer screening in transgender men and women.
外科肿瘤学会致力于减少对性少数群体和性别少数群体造成不利影响的健康差距。跨性别者是一个社会弱势群体，他们经常遭受歧视，并接受不同的护理，导致癌症治疗效果不佳。跨性别者的乳腺癌发病率与顺性别者的发病率不同，但几乎没有证据可以量化这些差异，并指导基于证据的筛查和预防。跨性别患者的乳腺癌筛查指南尚无共识。在这篇综述中，我们讨论了公平获得乳腺癌护理的障碍、乳腺癌发病的危险因素以及支持跨性别男性和女性进行乳腺癌筛查的现有数据。
